Skip to main content
UniHealth

Doctor search

Jeffrey Goldberg, MD

Ophthalmology · Stanford

NPI 1417158114

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Goldberg’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A124021 · Current

Licensed to practise in California · since 2012 · expires 2028-09-30 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Florida ME102139Medical Doctor · since 2008 · expires 2014-01-31
    Null And VoidNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

2 placements

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Education

  • Stanford University, Stanford California · MD1995–2003Medical school

Residency and fellowship

  • Bascom Palmer Eye Inst., OphthalmologyMIAMI, FL · 2005–2008
  • Santa Clara Valley Med Ctr., Transitional YearSAN JOSE, CA · 2003–2004

What else the board holds

Hospitals they may admit to

Where the clinician told their state board they may admit and treat patients.

  • Anne Bates Leach Eye Hospital · FL
  • University of Miami Hospital and Clinics · FL

Also licensed in

States the clinician told their board they are also licensed in. Only the states we check are verified.

Florida

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$24,924

Medicare paid this office $24,924 for 107 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)92$8,546$51
Return visit (30+ min)29$3,115$74
Exam of visual field with extended testing76$2,467$22
Imaging of optic nerve43$772$17
Imaging of retina21$600$22

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

107 Original Medicare patients in 2024. Average age 76 · Women 54% · Also on Medicaid 12% · Health risk score 1.07. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 64% · Diabetes 27% · Chronic kidney disease 25% · Coronary heart disease 21% · Cancer 19% · Atrial fibrillation 17% · Depression 13%.

The office billed $128,337, Medicare allowed $34,629 and paid $24,924; for 424 services of 20 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024107424761.07$128,337$24,924
2023121453751.06$165,613$32,201
2022113462750.97$145,873$28,841
2021113495750.98$156,022$32,456
202094361741.13$149,719$24,756
2019109461750.99$124,883$24,198
2018114445740.96$189,174$31,867
2017105339741.15$80,583$16,655
201644132711.18$52,904$8,697
201599315751.09$93,969$20,444
201495574751.05$216,758$48,880
201367295741.15$81,506$18,269

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Short return visit (20+ min)93$8,289$52
Return visit (30+ min)37$4,441$82
Exam of visual field with extended testing91$2,737$23
Imaging of optic nerve47$900$19
Imaging of retina22$513$21

2022: 5 services

Original Medicare services billed in 2022
Short return visit (20+ min)84$7,838$49
Return visit (30+ min)32$3,399$83
Exam of visual field with extended testing85$2,691$21
Imaging of optic nerve62$1,359$19
Imaging of retina13$523$22

2021: 5 services

Original Medicare services billed in 2021
Short return visit (20+ min)81$6,875$52
Return visit (30+ min)53$5,214$74
Exam of visual field with extended testing88$3,221$22
Imaging of optic nerve63$1,391$19
Imaging of retina11$307$24

2020: 3 services

Original Medicare services billed in 2020
Short return visit (20+ min)78$5,927$40
Exam of visual field with extended testing68$2,005$21
Imaging of optic nerve50$950$18

2019: 5 services

Original Medicare services billed in 2019
Short return visit (20+ min)92$6,790$40
Exam of visual field with extended testing78$3,075$23
Imaging of optic nerve67$1,469$18
New patient visit (30+ min)21$1,270$60
Imaging of retina13$344$21

2018: 4 services

Original Medicare services billed in 2018
Short return visit (20+ min)77$5,918$41
Exam of visual field with extended testing68$3,132$23
New patient visit (30+ min)29$1,767$61
Imaging of optic nerve45$1,232$19

2017: 5 services

Original Medicare services billed in 2017
Short return visit (20+ min)64$3,788$44
Exam of visual field with extended testing46$1,954$24
New patient visit (30+ min)27$1,535$57
Short return visit33$1,409$22
Imaging of optic nerve31$822$21

2016: 4 services

Original Medicare services billed in 2016
Short return visit (20+ min)20$1,368$41
New patient visit (30+ min)18$1,017$57
Exam of visual field with extended testing25$801$24
Imaging of optic nerve11$312$24

2015: 6 services

Original Medicare services billed in 2015
Short return visit (20+ min)66$5,491$52
Exam of visual field with extended testing59$3,029$47
Established patient complete exam of visual system13$994$71
Imaging of optic nerve26$842$32
Exam of the internal drainage system of eye19$415$22
Ultrasound scan of cornea to determine thickness16$185$12

2014: 11 services

Original Medicare services billed in 2014
Established patient complete exam of visual system49$7,068$94
Short return visit (20+ min)49$4,766$58
Exam of visual field with extended testing59$3,243$47
Imaging of optic nerve43$1,445$34
Photography of the retina23$1,378$60
Examination of eye by ophthalmoscope with retinal drawing33$1,376$20
Return visit (30+ min)11$1,054$88
Measurement of corneal curvature and depth of eye11$1,038$61
Exam of the internal drainage system of eye37$887$23
Examination of eye by ophthalmoscope with retinal drawing16$636$21
Ultrasound scan of cornea to determine thickness39$459$11

2013: 8 services

Original Medicare services billed in 2013
Established patient complete exam of visual system14$1,973$104
Short return visit (20+ min)22$1,781$59
Exam of visual field with extended testing22$1,168$49
Exam of the internal drainage system of eye35$830$22
Examination of eye by ophthalmoscope with retinal drawing15$695$24
Examination of eye by ophthalmoscope with retinal drawing11$532$20
Ultrasound scan of cornea to determine thickness25$297$12
Short return visit (20+ min)17$161$9

Drugs they prescribed that Part D paid

$27,545

Pharmacies billed $27,545 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 131) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

53 generic and 78 brand-name prescriptions · $27,545 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Rhopressa14$6,292$449
Brimonidine11$2,320$211
Prednisolone Acetate12$638$53
Latanoprost43$415$10

Year by year

Part D prescribing by year
2024131410% (0)60%$27,545
2023153370% (0)75%$52,975
2022130390% (0)73%$34,741
2021274450% (0)68%$670,475
2020239410% (0)77%$65,915
2019168360% (0)67%$33,139
2018158410% (0)52%$26,087
2017120330% (0)60%$28,608
2016100300% (0)49%$15,389
2015236490% (0)45%$22,320
201424061None34%$21,072
20139841420% (0)52%$73,654

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Part D drugs prescribed in 2023
Rhopressa20$14,281$714
Rocklatan13$6,817$524
Cosopt Pf12$2,469$206
Brimonidine11$2,410$219
Latanoprost26$593$23
Dorzolamide13$567$44

2022: 3 drugs

Part D drugs prescribed in 2022
Rhopressa36$19,196$533
Latanoprost20$512$26
Dorzolamide11$134$12

2021: 7 drugs

Part D drugs prescribed in 2021
Oxervate24$614,579$25,607
Rhopressa55$24,436$444
Combigan15$5,115$341
Prednisolone Acetate19$955$50
Latanoprost29$829$29
Dorzolamide-Timolol14$462$33
Brimonidine22$445$20

2020: 7 drugs

Part D drugs prescribed in 2020
Rhopressa72$24,079$334
Lumigan17$6,413$377
Simbrinza16$2,628$164
Prednisolone Acetate13$872$67
Dorzolamide-Timolol11$791$72
Brimonidine16$716$45
Latanoprost15$285$19

2019: 6 drugs

Part D drugs prescribed in 2019
Rhopressa19$5,905$311
Lumigan14$5,050$361
Simbrinza20$4,258$213
Rocklatan11$3,024$275
Latanoprost22$331$15
Timolol Maleate19$241$13

2018: 3 drugs

Part D drugs prescribed in 2018
Travatan Z21$8,745$416
Latanoprost58$1,219$21
Brimonidine15$676$45

2017: 2 drugs

Part D drugs prescribed in 2017
Travatan Z24$10,945$456
Latanoprost38$580$15

2016: 1 drug

Part D drugs prescribed in 2016
Latanoprost44$580$13

2015: 4 drugs

Part D drugs prescribed in 2015
Alphagan P26$5,391$207
Azopt16$3,562$223
Latanoprost121$1,715$14
Brimonidine12$1,626$136

2014: 6 drugs

Part D drugs prescribed in 2014
Brimonidine16$1,645$103
Latanoprost93$1,458$16
Prednisolone Acetate16$1,182$74
Dorzolamide-Timolol24$655$27
Timolol Maleate25$205$8
Diclofenac11$133$12

2013: 13 drugs

Part D drugs prescribed in 2013
Lumigan111$13,595$122
Travatan Z98$11,695$119
Combigan54$6,569$122
Latanoprost214$3,728$17
Dorzolamide-Timolol101$3,379$33
Brimonidine118$3,285$28
Azopt23$2,954$128
Methazolamide19$1,587$84
Dorzolamide38$987$26
Timolol Maleate91$918$10
Prednisolone Acetate30$452$15
Levobunolol12$210$17
Diclofenac16$201$13

Money from drug and device companies

$14,470 in 2025

Industry payments by year
2025610$14,068$14,470
2024513None$921
202367$2,550$2,896
2022717$6,600$10,113
202157$4,218$4,526
2020510$13,040$13,108
2019721$10,100$10,703

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Neurotech PharmaceuticalsEncelto$11,725
2 payments
  • Consulting for Encelto · 2025-12-03 · $6,650
  • Consulting for Encelto · 2025-10-03 · $5,075
Kowa Pharmaceuticals AmericaNone$1,500
1 payment
  • Honoraria · 2025-11-06 · $1,500
BioCryst PharmaceuticalsNone$843
1 payment
  • Consulting · 2025-02-05 · $843
Alcon VisionHydrus Microstent$300
4 payments
  • Meals for Hydrus Microstent · 2025-09-17 · $52
  • Meals for Hydrus Microstent · 2025-03-11 · $69
  • Meals for Hydrus Microstent · 2025-02-13 · $65
  • Meals for Rocklatan · 2025-01-21 · $115
GlaukosNone$64
1 payment
  • Meals · 2025-01-21 · $64
Dompe USOxervate$37
1 payment
  • Meals for Oxervate · 2025-05-22 · $37
See all 10 published payments
Every published payment
Neurotech PharmaceuticalsConsulting · 2025-12-03Encelto$6,650
Kowa Pharmaceuticals AmericaHonoraria · 2025-11-06None$1,500
Neurotech PharmaceuticalsConsulting · 2025-10-03Encelto$5,075
Alcon VisionMeals · 2025-09-17Hydrus Microstent$52
Dompe USMeals · 2025-05-22Oxervate$37
Alcon VisionMeals · 2025-03-11Hydrus Microstent$69
Alcon VisionMeals · 2025-02-13Hydrus Microstent$65
BioCryst PharmaceuticalsConsulting · 2025-02-05None$843
Alcon VisionMeals · 2025-01-21Rocklatan$115
GlaukosMeals · 2025-01-21None$64
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $921

Payments by company in 2024
GlaukosGonioprism Clip$326
4 payments
  • Meals for Gonioprism Clip · 2024-06-04 · $79
  • Meals for Gonioprism Clip · 2024-06-04 · $79
  • Meals · 2024-05-28 · $99
  • Meals for Idose · 2024-01-14 · $71
Alcon VisionRocklatan$264
4 payments
  • Meals for Hydrus Microstent · 2024-08-14 · $68
  • Meals for Hydrus Microstent · 2024-07-24 · $43
  • Meals for Rocklatan · 2024-03-13 · $41
  • Meals for Rocklatan · 2024-01-17 · $112
Sight SciencesOmni Surgical System$195
2 payments
  • Meals for Omni Surgical System · 2024-04-17 · $68
  • Meals for Omni Surgical System · 2024-02-29 · $127
Carl Zeiss MeditecPlex Elite$111
2 payments
  • Meals for Plex Elite · 2024-05-06 · $95
  • Gift for Plex Elite · 2024-05-06 · $16
Johnson & Johnson Surgical VisionTecnis Simplicity$24
1 payment
  • Meals for Tecnis Simplicity · 2024-01-25 · $24

2023: $2,896

Payments by company in 2023
Thea PharmaIyuzeh$2,550
1 payment
  • Consulting for Iyuzeh · 2023-02-14 · $2,550
Carl Zeiss MeditecCirrus Hd-Oct$150
1 payment
  • Meals for Cirrus Hd-Oct · 2023-01-17 · $150
Alcon VisionHydrus Microstent$85
2 payments
  • Meals for Hydrus Microstent · 2023-05-10 · $45
  • Meals for Centurion · 2023-02-13 · $40
Sight SciencesOmni Surgical System$45
1 payment
  • Meals for Omni Surgical System · 2023-02-08 · $45
IridexNone$34
1 payment
  • Meals · 2023-03-09 · $34
Johnson & Johnson Surgical VisionTecnis Iol$33
1 payment
  • Meals for Tecnis Iol · 2023-01-12 · $33

2022: $10,113

Payments by company in 2022
Alcon ResearchNone$6,945
5 payments
  • Consulting · 2022-10-21 · $4,900
  • Travel · 2022-09-23 · $219
  • Travel · 2022-09-23 · $367
  • Travel · 2022-09-23 · $549
  • Travel · 2022-09-23 · $910
Thea PharmaNone$1,700
2 payments
  • Consulting · 2022-11-09 · $850
  • Consulting · 2022-07-08 · $850
Alcon VisionAcrysof Iq Panoptix Uv Iol$736
5 payments
  • Meals for Acrysof Iq Panoptix Uv Iol · 2022-09-26 · $35
  • Meals for Hydrus Microstent · 2022-09-23 · $33
  • Travel · 2022-09-23 · $250
  • Travel · 2022-09-23 · $367
  • Meals for Acrysof Iq Panoptix Uv Iol · 2022-04-13 · $51
Nova EyeNone$314
1 payment
  • Meals · 2022-04-21 · $314
Carl Zeiss MeditecRescan 700$239
2 payments
  • Meals for Plex Elite · 2022-02-09 · $33
  • Meals for Rescan 700 · 2022-01-17 · $206
Regeneron PharmaceuticalsNone$141
1 payment
  • Meals · 2022-05-02 · $141
Carl Zeiss Meditec USANone$37
1 payment
  • Meals · 2022-06-06 · $37

2021: $4,526

Payments by company in 2021
Carl Zeiss MeditecNone$2,218
2 payments
  • Consulting · 2021-11-12 · $2,040
  • Meals · 2021-05-11 · $178
F. Hoffmann-La Roche AGNone$2,178
1 payment
  • Consulting · 2021-07-01 · $2,178
Alcon VisionAcrysof Iq Panoptix$49
1 payment
  • Meals for Acrysof Iq Panoptix · 2021-05-11 · $49
Sight SciencesOmni(R) Surgical System (US)$49
2 payments
  • Meals for Omni(R) Surgical System (US) · 2021-10-13 · $24
  • Meals for Omni(R) Surgical System (US) · 2021-02-10 · $25
Nobel Biocare USANone$32
1 payment
  • Meals · 2021-08-03 · $32

2020: $13,108

Payments by company in 2020
Aerie PharmaceuticalsNone$5,940
5 payments
  • Consulting · 2020-03-12 · $660
  • Consulting · 2020-02-18 · $1,320
  • Consulting · 2020-02-18 · $1,980
  • Consulting · 2020-02-11 · $990
  • Consulting · 2020-02-07 · $990
Carl Zeiss MeditecCirrus Hd-Oct$5,100
2 payments
  • Paid to speak or teach for Cirrus Hd-Oct · 2020-09-18 · $1,700
  • Paid to speak or teach for Cirrus Hd-Oct · 2020-06-11 · $3,400
PTC TherapeuticsNone$2,000
1 payment
  • Consulting · 2020-06-22 · $2,000
Sight SciencesOmni$49
1 payment
  • Meals for Omni · 2020-04-01 · $49
Carl Zeiss Meditec AGNone Specified$19
1 payment
  • Gift for None Specified · 2020-06-09 · $19

2019: $10,703

Payments by company in 2019
Aerie PharmaceuticalsRhopressa$5,179
11 payments
  • Meals · 2019-10-10 · $125
  • Consulting · 2019-09-19 · $500
  • Meals · 2019-08-30 · $9
  • Consulting · 2019-07-05 · $2,310
  • Meals for Rhopressa · 2019-04-30 · $3
  • Meals for Rhopressa · 2019-04-16 · $148
  • Consulting for Rocklatan · 2019-04-12 · $500
  • Consulting for Rocklatan · 2019-03-28 · $500
  • Consulting for Rhopressa · 2019-03-28 · $1,000
  • Meals for Rhopressa · 2019-03-14 · $75
  • Meals for Rhopressa · 2019-01-23 · $10
Carl Zeiss MeditecCirrus Hd-Oct$3,070
5 payments
  • Travel for Cirrus Hd-Oct · 2019-04-12 · $60
  • Consulting for Cirrus Hd-Oct · 2019-04-12 · $2,380
  • Travel for Cirrus Hd-Oct · 2019-04-12 · $54
  • Meals · 2019-03-13 · $27
  • Consulting for Callisto Eye · 2019-02-15 · $550
Regeneron PharmaceuticalsNone$1,240
1 payment
  • Consulting · 2019-04-18 · $1,240
GenentechLucentis$1,120
1 payment
  • Consulting for Lucentis · 2019-08-28 · $1,120
Alcon VisionPanoptix$37
1 payment
  • Meals for Panoptix · 2019-10-21 · $37
Mallinckrodt EnterprisesActhar$29
1 payment
  • Meals for Acthar · 2019-04-20 · $29
Sight SciencesOmni$29
1 payment
  • Meals for Omni · 2019-05-22 · $29

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Carl Zeiss Meditec, Inc. · The Collection of Oct and Oct Angiography Data From Human Eyes With A Variety of Eye Diseases With Plex Elite 9000. · 2019Their institution$48,336

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1417158114
Licence
CA A124021, FL ME102139California A124021: Current · expires 2028-09-30Florida ME102139: Null And Void
Trained
Stanford University School of Medicine, 2003
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207WX0009X (207WX0009X); Federal specialty code 207W00000X (207W00000X)
Mailing address
2452 Watson Ct Ste 2700, Byers Eye Institute at Stanford, Palo Alto, CA, 94303
NPI first listed
2007-05-30
NPI last updated
2024-04-04
NPI record certified
2024-04-04

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 2452 Watson Ct Ste 2700, Palo Alto, CA, 94303